Ledipasvir

Ledipasvir

Ledipasvir

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: 99%
  • Payment Terms : L/C,D/P,T/T,Other

Keywords

GS5885 high purity Ledipasvir Anti HCV APIs CAS 1256388-51-8 / Ledipasvir

Quick Details

  • Appearance:white powder
  • Application:Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used
  • PackAge:For small quantity: Bag Commercial quantity: fiber drum or Tin Or as per customers required
  • ProductionCapacity:10|Kilogram|Month
  • Storage:Store in a cool, dry place and keep away from direct strong light.
  • Transportation:air or ocean or rail or parcel post

Superiority:

SUNSANTA
  We are one of the leading exporters in China in the fields of active pharma
ingredients including oncology drug, prostaglandin, anti-HIV drug, cardiovascular
drug, diabetes drug, anti-inflammatory drug, urinary system drug, cosmetics peptide
and intermediate, dyestuff & pigment and kinds of package materials. 
  We specialize in synthesis of novel organic compounds, process development
and manufacturing of pharmaceutical and fine organic chemicals from gram to kilogram quantity.
  We supply
1.in very competitive price;
2.Quality Guaranteed;
3.Fast Delivery;
4.Payment:L/C;D/P;TT;;Paypal.
5.On-time shipment and pre-shipment product quality safeguards.

Details:

1   Specification

   Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed .[1] It is currently in Phase III clinical trials.[2] It is being studied in combination with other direct-acting antiviral agents that interfere with HCV replication. Ledipasvir is an inhibitor of the hepatitis C virus HCV NS5A protein. Ledipasvir is being tested in interferon-free regimens with other direct-acting antiviral agents for hepatitis C. Data presented at the 20th Conference on Retroviruses and Opportunistic Infections in March 2013 showed that a triple regimen of the nucleotide analogue inhibitor sofosbuvir, ledipasvir, and ribavirin produced a 12-week post-treatment sustained virological response (SVR12) rate of 100% for both treatment-naive patients and prior non-responders with HCV genotype 1.[3][4] Gilead is developing a sofosbuvir + ledipasvir coformulation that is being tested with and without ribavirin.

 

  Ledipasivir CAS 1256388-51-8 Brand: SUNSANTA
  MSDS: Avaiable
MF : C49H54F2N8O6 Sample: Avaiable

Category: Anti HCV

 Min order: 1 grams

Quality standard: In-House

 Place of Origin:China
Introduction    Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG interferon or ribavirin.
Character White to kind of white powder
Remark

Our products are limited to scientific research and production use only .Our products will not be sold to countires and regions under administrative and patent protections.

We can supply other APIs  as follow:  

                sofosbuvir   CAS 1190307-88-0

            Daclatasvir  CAS 1009119-64-5

2   Quality Specification:   

     Contact SUNSANTA for updated version COA

3   Package details:

  For small quantity: Bag  Commercial quantity: fiber drum or Tin  Or as per customers required  

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View